New Screening Methods Encourage Colorectal Cancer Prevention in Florida

Colorectal cancer screenings are essential for early detection, yet many individuals in Florida are not participating. As of now, only 65.5% of eligible Floridians aged 45 and older are up to date on these important screenings. This statistic poses a significant health risk, as colorectal cancer can be particularly lethal when diagnosed at an advanced stage. In fact, the five-year survival rate for early-stage colorectal cancer is 91%.

In recent years, Florida has seen an alarming rise in advanced-stage cases of colorectal cancer, particularly among low-income populations. Approximately 60% of adults on Medicaid in Florida have not undergone screening, highlighting disparities in healthcare accessibility and awareness. The need for effective solutions to bridge this gap has never been more urgent.

Many individuals delay screenings because they find traditional methods uncomfortable or invasive. Colonoscopies, while highly effective, often come with a cumbersome preparation process that deters potential candidates. Additionally, stool-based tests can provoke anxiety due to their nature. These barriers contribute to a significant screening gap across the state and the nation.

Recognizing the need for alternative options, new non-invasive blood tests, such as the Shield test, have been introduced. This test, which is the first FDA-approved blood test for primary colorectal cancer, offers an easier method for detection. Blood-based screening can be conducted during a regular doctor’s visit, eliminating the need for extensive preparation.

Ute Harshbarger, a travel agent based in Davenport, shared her positive experience with this new screening method. After discussing her options with her physician, she chose to undergo the blood test. “To my surprise, it was just a quick blood draw at my doctor’s office. There was no special prep or time-consuming process,” she remarked, expressing relief and empowerment after the experience.

The introduction of these new screening methods allows individuals to prioritize their health without the apprehension that often accompanies traditional procedures. Harshbarger emphasized that, for her, staying healthy means being present for her family and enjoying activities she loves, such as planning trips to Disney and exploring new travel destinations.

Screening for colorectal cancer transcends merely checking off a box; it is about giving oneself a fighting chance against a potentially deadly disease. As awareness grows around the availability of non-invasive screening options, it is crucial that individuals engage in conversations with their healthcare providers about their screening choices.

In conclusion, the introduction of innovative methods like the Shield test offers hope for increasing colorectal cancer screening rates in Florida. By making these procedures more accessible and less intimidating, the healthcare system can better serve populations at risk and ultimately save lives. Engaging in dialogue with doctors about screening options could be one of the most important steps individuals take for their health and future.